ArticleOncotarget2017

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.

Stine Dam Henriksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.